Last reviewed · How we verify
Ropivicaine
Ropivicaine is a Small molecule drug developed by Henry Ford Health System. It is currently FDA-approved. Also known as: naropin, Naropin, Trans-Abdominis Plane Block, ropivicaine, naropin.
Ropivacaine is a small molecule local anesthetic drug belonging to the amino amide group. It is marketed under the brand name Naropin by AstraZeneca and has been used in various clinical trials for conditions such as pectus excavatum, mastectomy, and breast cancer.
At a glance
| Generic name | Ropivicaine |
|---|---|
| Also known as | naropin, Naropin, Trans-Abdominis Plane Block, ropivicaine, naropin |
| Sponsor | Henry Ford Health System |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate (PHASE4)
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- To Compare Post-op Analgesic Effectiveness of Ropivicaine+Dexamethasone and Ropivacane+Dexmetomidine in TAP Block in Stoma Reversal Under GA in Terms of Duration of Analgesia. (PHASE2, PHASE3)
- Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies (NA)
- Randomized Controlled Trial for Ankle Fracture Pain Control (PHASE4)
- PVB vs Ketamine/Lidocaine in Rib Fracture Patients (EARLY_PHASE1)
- "The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors" (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ropivicaine CI brief — competitive landscape report
- Ropivicaine updates RSS · CI watch RSS
- Henry Ford Health System portfolio CI
Frequently asked questions about Ropivicaine
What is Ropivicaine?
Who makes Ropivicaine?
Is Ropivicaine also known as anything else?
What development phase is Ropivicaine in?
Related
- Manufacturer: Henry Ford Health System — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: naropin, Naropin, Trans-Abdominis Plane Block, ropivicaine, naropin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing